Gain Therapeutics, Inc. (Nasdaq: GANX) ("Gain", or the "Company"), a clinical-stage biotechnology company leading the discovery and development of the ...

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

Wishing a happy 4-0 to these actors, athletes, singers and creatives The post 40 Celebrities Turning 40 in 2025: Keira ...

A federal Judge said Prince Harry's immigration records were "likely" to be unsealed but cautioned that the court would take ...

The mother is accused of lying about her child’s medical condition while also reportedly not refilling medication that had been prescribed to her daughter.

Attorney General Pam Bondi discusses her hopes for the future of the Department of Justice and her aim to bring it back to ...

In her role as COO of FamilyLinks, Jackson started a number of initiatives, including the county’s first treatment program ...

The series adaptation of the Robert McCammon novel “Swan Song” has found its writer, Variety has learned exclusively. Russell ...

Jeff Bezos’s $10 billion climate and biodiversity fund has halted its funding of one of the world’s most important climate ...

The Metropolitan Police Department has an unlikely partner in its technology-backed crime fighting efforts. It’s Ben Horowitz ...

Fitness star Jillian Michaels discusses the speed that President Donald Trump is enacting his promised agenda and how he should be an 'inspiration' to everyone on ‘Jesse Watters Primetime.’ ...